Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Yoon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Gene Therapy|January 16, 2004
Spine fusion by gene therapyS T Yoon, S D Boden
Immunity|October 1, 1994
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activityS T Yoon, U Dianzani, K Bottomly, et al.
Journal of Pediatric Orthopedics|May 24, 2001
Osteochondral lesions of the capitellum in pediatric patients: role of magnetic resonance imagingR E Bowen, N Y Otsuka, S T Yoon, et al.
Skeletal Radiology|September 9, 1999
Fibrogenesis imperfecta ossium: imaging correlation in three new patientsC S Wang, L S Steinbach, J B Campbell, et al.
Spine|October 21, 2010
Do the adjacent level intervertebral discs degenerate after a lumbar spinal fusion? An experimental study using a rabbit modelKosaku Higashino, Takahiko Hamasaki, Jin Hwan Kim, et al.
Acta Neurochirurgica|July 12, 2008
The AdLMP-1 transfection in two different cells; AF cells, chondrocytes as potential cell therapy candidates for disc degenerationS U Kuh, Y Zhu, J Li, et al.
Immunity|April 1, 1996
The specificity and orientation of a TCR to its peptide-MHC class II ligandsD B Sant'Angelo, G Waterbury, P Preston-Hurlburt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
The orientation of a T cell receptor to its MHC class II:peptide ligandsS C Hong, D B Sant'Angelo, B N Dittel, et al.
Global Spine Journal|December 20, 2013
Improving the clinical evidence of bone graft substitute technology in lumbar spine surgeryWellington K Hsu, M S Nickoli, J C Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Gene Therapy|January 16, 2004
Spine fusion by gene therapyS T Yoon, S D Boden
Immunity|October 1, 1994
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activityS T Yoon, U Dianzani, K Bottomly, et al.
Journal of Pediatric Orthopedics|May 24, 2001
Osteochondral lesions of the capitellum in pediatric patients: role of magnetic resonance imagingR E Bowen, N Y Otsuka, S T Yoon, et al.
Skeletal Radiology|September 9, 1999
Fibrogenesis imperfecta ossium: imaging correlation in three new patientsC S Wang, L S Steinbach, J B Campbell, et al.
Spine|October 21, 2010
Do the adjacent level intervertebral discs degenerate after a lumbar spinal fusion? An experimental study using a rabbit modelKosaku Higashino, Takahiko Hamasaki, Jin Hwan Kim, et al.
Acta Neurochirurgica|July 12, 2008
The AdLMP-1 transfection in two different cells; AF cells, chondrocytes as potential cell therapy candidates for disc degenerationS U Kuh, Y Zhu, J Li, et al.
Immunity|April 1, 1996
The specificity and orientation of a TCR to its peptide-MHC class II ligandsD B Sant'Angelo, G Waterbury, P Preston-Hurlburt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
The orientation of a T cell receptor to its MHC class II:peptide ligandsS C Hong, D B Sant'Angelo, B N Dittel, et al.
Global Spine Journal|December 20, 2013
Improving the clinical evidence of bone graft substitute technology in lumbar spine surgeryWellington K Hsu, M S Nickoli, J C Wang, et al.
Pageof 1